Download full-text PDF |
Source |
---|
Sci Adv
January 2025
Forest Entomology, Swiss Federal Research Institute WSL, Birmensdorf, Switzerland.
Understanding how land use affects temporal stability is crucial to preserve biodiversity and ecosystem functions. Yet, the mechanistic links between land-use intensity and stability-driving mechanisms remain unclear, with functional traits likely playing a key role. Using 13 years of data from 300 sites in Germany, we tested whether and how trait-based community features mediate the effect of land-use intensity on acknowledged stability drivers (compensatory dynamics, portfolio effect, and dominant species variability), within and across plant and arthropod communities.
View Article and Find Full Text PDFSci Adv
January 2025
Institute of Energy, School of Earth and Space Sciences, Peking University, Beijing 100871, China.
The origins of natural hydrogen in natural gas systems of sedimentary basins and the capacity of these systems to store hydrogen remain inadequately understood, posing crucial questions for the large-scale exploration of natural hydrogen. This study reports on the natural gas composition, stable carbon and hydrogen isotopic values, and helium isotopic values of gas samples collected from the Qingshen gas deposit within volcanic rocks of the Songliao Basin. Natural hydrogen primarily originates from water radiolysis, water-rock interactions (WRI), and mantle.
View Article and Find Full Text PDFJ Fungi (Basel)
January 2025
Food Science and Technology Program, Department of Life Sciences, BNU-HKBU United International College, Zhuhai 519087, China.
Mushrooms are valued for their culinary and medicinal benefits, containing bioactive compounds like polysaccharides, terpenoids, phenolics, lectins, and ergosterols. This review aims to encourage research on by summarizing its chemistry, health benefits, pharmacology, and potential therapeutic applications. Molecules from offer anti-diabetic, antioxidant, anti-tumor, hepatoprotective, and anti-bacterial effects.
View Article and Find Full Text PDFRes Pract Thromb Haemost
January 2025
Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Background: Emicizumab, a bispecific antibody that mimics factor (F)VIII, has significantly improved hemophilia A management. Although emicizumab levels can be measured, tools for estimating the hemostatic efficacy of emicizumab are lacking. Thrombin generation (TG) assays can distinguish bleeding phenotypes in persons with hemophilia A on FVIII prophylaxis and may also be used during emicizumab therapy.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Institute of Pharmacology and the Gaston H. Glock Research Laboratories for Exploratory Drug Development, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Objective: The expanding field of hematopoietic cell transplantation (HCT) for non-malignant diseases, including those amenable to gene therapy or gene editing, faces challenges due to limited donor availability and the toxicity associated with cell collection methods. Umbilical cord blood (CB) represents a readily accessible source of hematopoietic stem and progenitor cells (HSPCs); however, the cell dose obtainable from a single cord blood unit is frequently insufficient. This limitation can be addressed by enhancing the potency of HSPCs, specifically their capacity to reconstitute hematopoiesis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!